Foresee Pharmaceuticals Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-1,226	-1,081	-1,036	-472.64	-569.27	-510.71
Depreciation & Amortization	68.44	79.1	73.45	50.93	51.16	48.71
Other Amortization	5.39	1.42	0.18	0.22	0.32	0.77
Loss (Gain) From Sale of Assets	-	0.03	0.2	0.31	0.13	0.06
Asset Writedown & Restructuring Costs	-	-	-	1.16	-	-
Loss (Gain) From Sale of Investments	-	-	-	-0.29	-0.8	-0.52
Stock-Based Compensation	46.94	49.82	50.77	40.18	23.92	22.89
Other Operating Activities	-5.34	-3.68	0.5	0.69	-9.42	4.56
Change in Accounts Receivable	-18.79	33.58	-49.64	-16.27	-	0.01
Change in Inventory	3.83	-57.08	49.61	-151.53	40.1	32.82
Change in Accounts Payable	-40.5	52.29	-10.72	22.85	-	7.12
Change in Unearned Revenue	-158.58	-114.5	-1.01	-1.8	160.76	23.77
Change in Other Net Operating Assets	-38.04	-133.67	35.41	-4.79	34.76	-1.27
Operating Cash Flow	-1,362	-1,174	-887.56	-233.22	-213.33	-674.8
Capital Expenditures	-0.84	-149.59	-46.28	-58.07	-6.86	-12.79
Sale of Property, Plant & Equipment	-	0.21	0.23	-	-	-
Sale (Purchase) of Intangibles	-15.91	-6.36	-	-	-0.54	-15.4
Investment in Securities	-	267.5	-249	100	25	-125
Other Investing Activities	-0.43	1.06	-1.03	-1.23	0.02	0.15
Investing Cash Flow	-17.18	112.82	-296.08	40.7	17.62	-153.03
Short-Term Debt Issued	-	800	300	-	-	40
Long-Term Debt Issued	-	100	-	-	-	84.53
Total Debt Issued	350.83	900	300	-	-	124.53
Short-Term Debt Repaid	-	-850	-100	-	-30.07	-9.93
Long-Term Debt Repaid	-	-17.09	-15.52	-11.35	-84.1	-10.63
Total Debt Repaid	-369	-867.09	-115.52	-11.35	-114.17	-20.56
Net Debt Issued (Repaid)	-18.17	32.91	184.48	-11.35	-114.17	103.97
Issuance of Common Stock	1,561	1,378	1,319	14.21	38.43	1,425
Financing Cash Flow	1,543	1,411	1,504	2.86	-75.74	1,529
Foreign Exchange Rate Adjustments	-23.32	8	-0.09	7.73	-2.23	-3.71
Net Cash Flow	139.76	357.62	320.17	-181.93	-273.68	697.1
Free Cash Flow	-1,363	-1,323	-933.84	-291.29	-220.19	-687.58
Free Cash Flow Margin	-262.35%	-316.07%	-478.80%	-96.61%	-97.42%	-298.38%
Free Cash Flow Per Share	-9.04	-9.64	-7.34	-2.47	-1.88	-6.78
Cash Interest Paid	5.52	6.47	2.68	0.4	0.76	0.92
Cash Income Tax Paid	24.11	51.71	46.01	29.01	41.66	26.65
Levered Free Cash Flow	-917.71	-753.85	-616.79	-402.03	-236.28	-259.81
Unlevered Free Cash Flow	-914.14	-749.65	-615.01	-401.78	-235.85	-259.19
Change in Working Capital	-252.07	-219.37	23.64	146.23	290.62	-240.55

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.